These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31582583)

  • 21. Activation of Flucloxacillin-Specific CD8+ T-Cells With the Potential to Promote Hepatocyte Cytotoxicity in a Mouse Model.
    Nattrass R; Faulkner L; Vocanson M; Antoine DJ; Kipar A; Kenna G; Nicolas JF; Park BK; Naisbitt DJ
    Toxicol Sci; 2015 Jul; 146(1):146-56. PubMed ID: 25877613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro.
    Govan JR; Fyfe JA
    J Antimicrob Chemother; 1978 May; 4(3):233-40. PubMed ID: 97259
    [No Abstract]   [Full Text] [Related]  

  • 23. Decreased INR response secondary to warfarin-flucloxacillin interaction.
    Garg A; Mohammed M
    Ann Pharmacother; 2009 Jul; 43(7):1374-5. PubMed ID: 19584391
    [No Abstract]   [Full Text] [Related]  

  • 24. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections.
    Calain P; Krause KH; Vaudaux P; Auckenthaler R; Lew D; Waldvogel F; Hirschel B
    J Infect Dis; 1987 Feb; 155(2):187-91. PubMed ID: 2949024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microanalysis of amoxicillin, flucloxacillin, and rifampicin in neonatal plasma.
    Pullen J; Stolk LM; Neef C; Zimmermann LJ
    Biomed Chromatogr; 2007 Dec; 21(12):1259-65. PubMed ID: 17604357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Methicillin-resistant" Staphylococcus aureus: reassessment by controlled trial in burns unit.
    Lowbury EJ; Lilly HA; Kidson A
    Br Med J; 1977 Apr; 1(6068):1054-6. PubMed ID: 322817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flucloxacillin associated neutropenia in children treated for bone and joint infections (J. Paediatr. Child Health 2005; 41: 48-51).
    Pietroni M
    J Paediatr Child Health; 2005; 41(9-10):534. PubMed ID: 16150078
    [No Abstract]   [Full Text] [Related]  

  • 28. Flucloxacillin hepatitis: an Australian epidemic--comment.
    Blackmore TK; Wesselingh SL; Gordon DL
    Aust N Z J Med; 1995 Oct; 25(5):537. PubMed ID: 8588780
    [No Abstract]   [Full Text] [Related]  

  • 29. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis.
    Leder K; Turnidge JD; Korman TM; Grayson ML
    J Antimicrob Chemother; 1999 Jan; 43(1):113-8. PubMed ID: 10381108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
    Schrenzel J; Harbarth S; Schockmel G; Genné D; Bregenzer T; Flueckiger U; Petignat C; Jacobs F; Francioli P; Zimmerli W; Lew DP;
    Clin Infect Dis; 2004 Nov; 39(9):1285-92. PubMed ID: 15494904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flucloxacillin in the treatment of infectious conditions in children.
    Price JD; Harding JW
    Curr Med Res Opin; 1975; 3(2):77-82. PubMed ID: 1139964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzylpenicillin versus flucloxacillin for penicillin-susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study.
    Henderson A; Harris P; Hartel G; Paterson D; Turnidge J; Davis JS; Tong SYC
    Int J Antimicrob Agents; 2019 Oct; 54(4):491-495. PubMed ID: 31181352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simplified oral flucloxacillin absorption test for patients requiring long-term treatment.
    Dijkmans AC; Hartigh Jd; van Dissel JT; Burggraaf J
    Ther Drug Monit; 2012 Jun; 34(3):356-8. PubMed ID: 22569354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of flucloxacillin in the treatment of serious staphylococcal infections in children].
    Saied H; Ben Attia M
    J Int Med Res; 1986; 14(5):261-6. PubMed ID: 3770291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flucloxacillin treatment of methicillin-'resistant' and sensitive staphylococcal infection.
    Kidson A; Lilly HA; Lowbury EJ
    J Antimicrob Chemother; 1979 Jul; 5(4):359-64. PubMed ID: 489489
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.
    Haag R
    Infection; 1986; 14(1):38-43. PubMed ID: 3957435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dicloxacillin and flucloxacillin twice daily with probenecid in staphylococcal infections. A clinical and pharmakokinetic evaluation.
    Hedström SA; Kahlmeter G
    Scand J Infect Dis; 1980; 12(3):221-5. PubMed ID: 7433922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agranulocytosis in rheumatoid arthritis associated with long-term flucloxacillin for staphylococcal osteomyelitis.
    Burton IE; Moussa KM; Sanders PA
    Acta Haematol; 1995; 94(4):196-8. PubMed ID: 8610477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
    Davis JS; Turnidge J; Tong S
    Int J Antimicrob Agents; 2018 Aug; 52(2):297-300. PubMed ID: 29499317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing prevalence of methicillin-resistant Staphylococcus aureus in remote Australian communities: implications for patients and clinicians.
    Guthridge I; Smith S; Horne P; Hanson J
    Pathology; 2019 Jun; 51(4):428-431. PubMed ID: 31000171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.